Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)
NEUROMIROIR2
Intensive Rehabilitation Program With Intensive Visual Numerical Simulation Device for Improving Distal Motor Performance and Upper Limb Functional Capacity in Subacute Hemiparetics After Stroke. Randomized Controlled Trial.
1 other identifier
interventional
66
1 country
5
Brief Summary
Hemiparesis is a common motor disorder after a stroke. The majority of patients do not recover functional use of their paretic upper limb. The use of mirror therapy allows the activation of the mirror neurons involved to stimulate brain plasticity after brain damage.The IVS (Intensive Visual Stimulation) device allows an easy implementation of mirror therapy by filming the valid upper limb and projecting the inverted image onto a screen placed above the parietal arm thus producing the illusion of movement of the parietal arm. The main hypothesis of this study is that the structured practice of a large number of upper limb targeted movement repetitions using an intensive visual numerical simulation device as a partial replacement for routine care (conventional occupational therapy) in the sub-acute phase of stroke will increase the active function (motor function and functional abilities) of the distal end of the upper limb compared to conventional rehabilitation. Objectives: This randomized controlled trial will evaluate the effects of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after the stroke, compared to a program with conventional care alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Dec 2019
Longer than P75 for not_applicable stroke
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2019
CompletedFirst Posted
Study publicly available on registry
October 8, 2019
CompletedStudy Start
First participant enrolled
December 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2028
March 18, 2026
March 1, 2026
7.6 years
October 7, 2019
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of motor performance score on the Fugl-Meyer sub-score wrist/hand
Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the sub-score wrist/hand includes items related to movements of the forearm (proximal arm), wrist, hand (distal arm) and speed/coordination during a finger-nose task. The total sub-score range between 0 and 30.
between Day1(day of program start), Week6 (end of the program)
Secondary Outcomes (4)
Change of motor performance score on the Fugl-Meyer
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
Change of motor capacity on Stroke Upper Limb Capacity Scale (SULCS)
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
Change of spasticity score of the elbow flexors, wrist flexors, finger flexors measured by the Modified Ashworth Scale (MAS)
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
Change in perceived stroke impact on the Stroke Impact Scale (SIS)
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
Study Arms (2)
Conventional Rehabilitation
ACTIVE COMPARATORat least 4 sessions/week for 6 weeks, from 1 hour of conventional upper limb rehabilitation by an occupational therapist.
Intensive Visual Simulation
EXPERIMENTALat least 4 sessions/week for 6 weeks, of 1 hour of upper limb rehabilitation including 45 minutes of conventional rehabilitation (occupational therapy) and 15 minutes of work with a medical device allowing intensive visual digital simulation.
Interventions
upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
* First week: observation, mentalization and then attempt to perform the movements on the screen. * Second and third weeks: production of analytical movements of wrist flexion/extension, pronation/supination, finger flexion/extension, thumb opposition. * From the 4th week until the end: depending on the patient's motor capacities, continuation of the work of the previous 2 weeks or introduction of more functional work with object manipulation, gripping work. Conventional rehabilitation upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Eligibility Criteria
You may qualify if:
- Age ≥18 years;
- Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline;
- Total sub-scores wrist and hand of th Fugl-Meyer \< 16
- Patient having agreed to sign an informed consent
- patient being affiliated to the French Social Security
You may not qualify if:
- Cognitive dysfunction or progressive intercurrent illness making effective communication or participation in the study impossible
- Phasic disorders that prevent the understanding of instructions
- Patient include in an other clinical trial
- Neurological conditions prior to stroke
- Rheumatological pathology of the hand and wrist
- Person under legal protection measure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimscollaborator
- Clinique Les Grands Chênescollaborator
- Clinique Napoléoncollaborator
- Clinique Mariéniacollaborator
- Clinique Verdaichcollaborator
- Clinique Les Trois Soleilslead
- Clinalliance Villiers-sur-Orgecollaborator
- Centre de Rééducation Fonctionnelle Pasoricollaborator
Study Sites (5)
CHU Sébastopol
Reims, Champagne-Ardenne, 51092, France
Clinique Napoléon
Saint-Paul-lès-Dax, Nouvelle-Aquitaine, 40990, France
Clinique Les Trois Soleils
Boissise-le-Roi, 77310, France
CRF Pasori
Cosne-Cours-sur-Loire, 58200, France
Clinalliance Villiers-sur Orge
Villiers-sur-Orge, 91700, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christophe DURET, MD
Clinique Les Trois Soleils
- PRINCIPAL INVESTIGATOR
Manuel Wiese, MD
Clinalliance Villiers-sur-Orge
- PRINCIPAL INVESTIGATOR
Nikolay DOBREV, MD
CRF PASORI
- PRINCIPAL INVESTIGATOR
François BOYER, Professor
Hôpital Sébastopol, CHU de Reims
- PRINCIPAL INVESTIGATOR
Caroline TERRACOL, MD
Clinique Marienia Inicea
- PRINCIPAL INVESTIGATOR
Jean-Marc GUEBLE, MD
Clinique Verdaich
- PRINCIPAL INVESTIGATOR
Adrien PETIT, MD
Clinique Les Grands Chênes Inicea
- PRINCIPAL INVESTIGATOR
Magali CAPLANNE, MD
Clinique Napoléon Inicea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2019
First Posted
October 8, 2019
Study Start
December 10, 2019
Primary Completion (Estimated)
July 31, 2027
Study Completion (Estimated)
July 31, 2028
Last Updated
March 18, 2026
Record last verified: 2026-03